San Francisco, CA, United States of America

Jo Ann Z Wilson

This inventor holds 2 USPTO granted patents. Top assignee: Effector Therapeutics, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jo Ann Z Wilson. Retrieved from https://idiyas.com/inventor/jo-ann-z-wilson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jo Ann Z Wilson: Innovator in Therapeutic Applications

Introduction

Jo Ann Z Wilson is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of therapeutic applications through his innovative work. With a total of 2 patents to his name, Wilson's inventions focus on the development of crystalline forms of Mnk inhibitors.

Latest Patents

Wilson's latest patents include the invention of crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione. These crystalline compounds serve as inhibitors of Mnk and have potential utility in various therapeutic applications, including the treatment of inflammation and different types of cancers.

Career Highlights

He is currently associated with Effector Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective treatments in the medical field.

Collaborations

Some of his notable coworkers include Siegfried Heinz Reich and Paul A Sprengeler, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Jo Ann Z Wilson's innovative contributions to the field of therapeutic applications highlight his role as a significant inventor. His work on Mnk inhibitors showcases the potential for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…